Use of nanoscale materials in commercial sunscreen products

Nanotechnology Law and Business

Volumn 9, Issue 1, 2012, Pages 74-86

  Cole, Michael F ^a   Bergeson, Lynn L ^a   Hutton, Carla N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL RISKS; FOOD AND DRUG ADMINISTRATION; NANO SCALE; NANO-SCALE MATERIALS; NANOSCALE TITANIUM DIOXIDE; PUBLIC INTEREST GROUPS; SUNSCREEN PRODUCTS; TECHNOLOGY ASSESSMENTS;

DRUG PRODUCTS; NANOTECHNOLOGY; PUBLIC RISKS; SUN HOODS; ZINC OXIDE;

NANOSTRUCTURED MATERIALS;

EID: 84873975124     PISSN: 15462080     EISSN: 1546203X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. International Center for Technology Assessment (Citizen Petition to FDA), Petition Requesting FDA Amend Its Regulations for Products Composed of Engineered Nanoparticles Generally and Sunscreen Drug Products Composed of Engineered Nanoparticles Specifically, Docket 2006P-0210 (MAY 16, 2006), available at http://www.fda.gov/ohrms/dockets/dockets/06p0210/06p0210.htm.
2. Journal of Drugs in Dermatology, Nanotechnology in cosmetics and sunscreens: an update (Oct. 2009), http://findarticles.com/p/articles/mi-m0PDG/ is-10-8/ai-n39372974/pg-2/?tag=content;col1 (last visited Mar. 12, 2012).
3. Consumers Union, New Report From Public Interest Groups Warns of Risks From Nanomaterials in Sunscreens (Aug. 19, 2009), http://www.consumersunion.org/ pub/core-product-safety/014360.html (last visited Mar. 12, 2012).
4. Barnsby J. Feder, Nanoparticles in Your Sunscreen: Too Hot to Handle, N.Y. Times (Aug. 14, 2007), available at http://bits.blogs.nytimes.com/2007/08/ 14/nanoparticles-in-your-sunscreen-too-hot-to-handle/ (last visited Mar. 12, 2012).
5. See id (In the article, the author, Barnaby J. Feder, concluded somewhat facetiously, "So who wins this ar-gument? Perhaps the folks who make beach umbrellas.").
6. W.S. Badger Company Inc., Zinc Oxide ; Nanoparticles in Sunscreens, http://www.badgerbalm.com/t-sunscreen-zinc-oxide-nanoparticles.aspx (last visited Mar. 12, 2012).
7. Letter from Michael Hansen, Ph.D., Senior Scientist, Consumers Union, to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, U.S. FDA (Oct. 30, 2008), available at http://www.consumersunion.org/pub/coreproductsafety/006254. html
8. See also Friends of the Earth Austral-ia, Nanotechnology Project, Companies deny consumers information on nano-ingredients in sunscreens, cosmet-ics, available at http://nano.foe.org.au/companies-deny-consumers- information-nano-ingredients-sunscreens-cosmetics (last visited Mar. 12, 2012)
9. Dept. of Health and Human Svcs., National Toxicology Program (NTP), Frequently Asked Questions (FAQs), http://ntp.niehs.nih.gov/?objectid=30302D16- F1F6-975E-7B315D93D4A1246F (last visited Mar. 12, 2012).
10. NAKISSA SADRIEH, PH.D., FDA CONSIDERATIONS FOR REGULATION OF NANOMATERIAL CONTAINING PRODUCTS (2006), available at www.fda.gov/ohrms/dockets/ac/06/ briefing/2006-4241B1-02-31-FDA-Nano%20Sadrieh%20nanotech%20presentation%20(2). pdf.
11. Id. See also FDA, Existing Public Private Partnerships: Public-Private Partnership Program Descriptions, http://www.fda.gov/AboutFDA/ PartnershipsCollaborations/PublicPrivatePartnershipProgram/ucm166082.htm (last visited Mar. 12, 2012).
12. See Rice University, Center for Biological and Environmental Nanotechnology, http://cben.rice.edu/showhome.aspx (last visited Mar. 12, 2012).
13. FDA, FDA Collaborations With NCI and NIST on Nanotechnology, http://www.fda.gov/AboutFDA/PartnershipsCollaborations/ PublicPrivatePartnershipProgram/ucm231125.htm (last visited Mar. 12, 2012).
14. FDA, News Release, FDA and Eight Academic and Research Institutions to Collaborate Under Nanotechnol-ogy Initiative (Mar. 10, 2009), available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm149541.htm.
15. FDA, Nanotechnology Toxicity Studies Support, http://www.accessdata.fda. gov/FDATrack/track-proj?program=nctr;id=NCTR-OSC-Nanotechnology-Toxicity- Studies-Support (last visited Mar. 12, 2012).
16. See FDA, FDA Nanotechnology Regulatory Science Research Categories: Selected FDA Publications Related to Applications of Nanotechnology, available at http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/ucm196697. htm.
17. NTP, Nanotoxicology Safety Initiative Projects, http://ntp.niehs.nih.gov/ ?objectid=303069A0-F1F6-975E-72D33ECBD3E11363 (The reference also discusses many other aspects of the NTP program.) (last visited Mar. 12, 2012).
18. EPA, Nanomaterial Case Studies: Nanoscale Titanium Dioxide in Water Treatment and in Topical Sunscreen (Final), EPA/600/R-09/057F (2010), available at http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=230972.
19. DTSC, Carbon Nanotube Information Call-In, http://www.dtsc.ca.gov/ TechnologyDevelopment/Nanotechnology/CNTcallin.cfm (last visited Mar. 12, 2012).
20. DTSC, Chemical Information Call-In - Nano Metals, Nano Metal Oxides, and Quantum Dots, http://www.dtsc.ca.gov/TechnologyDevelopment/Nanotechnology/ nanometalcallin.cfm (last visited Mar. 12, 2012).
21. See DTSC, SPONSORED FORUMS: PUBLIC WORKSHOP ON STATE AND FEDERAL NANOMATERIAL ACTIVITIES, available at http://www.dtsc.ca.gov/ TechnologyDevelopment/Nanotechnology/ArchivedSymposium.cfm.
22. DTSC, Safer Consumer Products Regulations, available at http://dtsc.ca.gov/SCPRegulations.cfm.
23. See Citizen Petition to FDA, supra note 2 for the comments filed by CTFA to the petition.
24. NIA was formed in 2005 by a group of companies from a variety of industry sectors, including healthcare, chemicals, automotive, materials processing, and consumer products. See its website at http://www.nanotechia.org/about-nia for more information (last visited Mar. 12, 2012).
25. NIA, PROSPEcT, http://www.nanotechia.org/prospect-project-20090101/ prospectproject20090101 (last vis-ited Mar. 12, 2012).
26. FDA, Center for Drug Evaluation and Research, What are over-the-counter (OTC) drugs and how are they approved?, http://www.fda.gov/AboutFDA/ Transparency/Basics/ucm194951.htm (last visited Mar. 12, 2012).
27. See FDA, Nanotechnology Task Force, http://www.fda.gov/ScienceResearch/ SpecialTopics/Nanotechnology/NanotechnologyTaskForce/default.htm (last visited Mar. 12, 2012).
28. FDA, EXECUTIVE REPORT, NANOTECHNOLOGY TASK FORCE REPORT 2007, available at http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/ NanotechnologyTaskForceReport2007/default.htm#execsummary.
29. See supra note 36. The principal guidance is discussed in Lynn L. Bergeson, FDA's Regulation of Nanotech-nology: Will the New Draft Guidance Help Industry?, 8 NANOTECHNOLOGY LAW ; BUSINESS 166 (2011).
30. Complaint of Plaintiffs, ICTA et al. v. Margaret A. Hamburg, M.D., CV 11 6592 (N.D. Cal.) (Dec. 21, 2011), available at http://www.icta.org/ nanotechnology/legal-actions-6/.